{"company":{"id":2168151,"name":"Obsidian Therapeutics","domain":"obsidiantx.com","url":"https://alion.io/company/obsidiantx"},"section":"news","answer":"Obsidian Therapeutics: 9 headlines on record, 4 headlines in the last 90 days. Its story counts 2 milestones.","figures":[{"label":"Headlines","value":"9"},{"label":"In 90 days","value":"4"},{"label":"Milestones","value":"2"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":8},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":2}],"news":[{"date":"2026-10-14","kind":"News","title":"Obsidian Therapeutics Inc OBX","source":"morningstar.com","url":"https://morningstar.com/stocks/xnas/obx/quote"},{"date":"2026-10-05","kind":"News","title":"Obsidian Therapeutics to Present Updated Amsoki-cel Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting","source":"marketscreener.com","url":"https://marketscreener.com/news/obsidian-therapeutics-to-present-updated-amsoki-cel-phase-1-2-data-in-advanced-melanoma-at-sitc-2026-ce785dd8db88fe24"},{"date":"2026-10-02","kind":"News","title":"Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/obsidian-therapeutics-present-updated-amsoki-130500031.html"},{"date":"2026-09-22","kind":"News","title":"Leerink Partners Initiates Obsidian Therapeutics at Outperform With $32 Price Target","source":"marketscreener.com","url":"https://marketscreener.com/news/leerink-partners-initiates-obsidian-therapeutics-at-outperform-with-32-price-target-ce785ad8da8af32c"},{"date":"2026-08-05","kind":"News","title":"Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/obsidian-therapeutics-announces-first-patient-110500423.html"},{"date":"2026-04-14","kind":"News","title":"PRN_FinancialWrapper","source":"PRNewswire","url":"https://markets.financialcontent.com/prnews/article/bizwire-2026-4-14-obsidian-therapeutics-and-galera-therapeutics-announce-merger-agreement-and-350-million-concurrent-private-placement"},{"date":"2024-11-04","kind":"Press release","title":"Obsidian Therapeutics to Present Preclinical Data Supporting OBX-115 and cytoDRiVE Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024","source":"businesswire.com","url":"https://businesswire.com/news/home/20241105359674/en/Obsidian-Therapeutics-to-Present-Preclinical-Data-Supporting-OBX-115-and-cytoDRiVE%C2%AE-Platform-at-the-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting-2024/"},{"date":"2024-07-08","kind":"Press release","title":"Obsidian Therapeutics Announces FDA Fast Track Designation for OBX-115 for the Treatment of Advanced Melanoma","source":"businesswire.com","url":"https://businesswire.com/news/home/20240709459610/en/Obsidian-Therapeutics-Announces-FDA-Fast-Track-Designation-for-OBX-115-for-the-Treatment-of-Advanced-Melanoma"}],"story":[{"title":"Raised a round Venture round $32.4M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1723046/000172304617000001/"},{"title":"Founded"}],"as_of":"2026-11-16","cite":"Obsidian Therapeutics, News. Alion, Nov 16, 2026. https://alion.io/company/obsidiantx/news","html_url":"https://alion.io/company/obsidiantx/news","json_url":"https://alion.io/company/obsidiantx/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-16T00:34:01Z"}}